Hem › Alzheimers sjukdom › Washington
Kliniska studier för Alzheimers sjukdom i Washington
17 studier för Alzheimers sjukdom söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
RekryterarFas 2
Ålder 55 till 90 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
RekryterarFas 2
Ålder 55 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1644, Seattle
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- University of Washington, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT00869817A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
RekryterarFas 2
Ålder 55 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Northwest Clinical Research Center, Bellevue
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
RekryterarFas 2
Ålder 55 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- EvergreenHealth Medical Center, Kirkland
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1644, Seattle
RekryterarFas 3
Ålder 55 till 90 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07011732Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Fred Hutchinson Cancer Center, Seattle
RekryterarObservationsstudieFriska volontärer välkomnaAnger ersättning till deltagare
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT06922188Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
RekryterarFas 2/3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
RekryterarFas 2/3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Northwest Clinical Research Center, Bellevue
- Universal Research Group, Tacoma
RekryterarFas 3
Ålder 55 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Washington Medical Center, Seattle
RekryterarFas 2
Ålder 50 till 85 · Alla kön · Uppdaterad 26 juni 2026 · NCT07094516Late Onset Alzheimer's Disease
- University of Washington, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 55 och äldre · Alla kön · Uppdaterad 18 maj 2026 · NCT05010603A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
Rekryterar
Ålder 60 och äldre · Alla kön · Uppdaterad 20 juli 2025 · NCT06411561Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.